Topic
biopharmaceuticals
2 stories related to this topic, newest first.
Benzingafinance20 days ago
Liquidia Board Member Sells 196,111 Shares for $14 Million
A board member at Liquidia sold nearly 200,000 shares on June 16. The transaction was disclosed in a regulatory filing on Tuesday.
Substrate placeholder — needs reviewfinance77 days ago
Outlook Therapeutics Announces $5 Million Registered Direct Offering
Outlook Therapeutics has announced a $5 million registered direct offering priced at $0.31 per share, including warrants. The offering is expected to close on April 23, 2026. This move provides the company with additional capital through a direct sale of securities.